Japan approves Novartis’ oral MS drug Gilenya

Gilenya, or Fingolimod, is the first approved oral disease modifying drug for MS.

Japan approves Novartis’ oral MS drug Gilenya

Postby MSUK » Wed Sep 28, 2011 1:09 am


Japanese regulatory authorities have approved Novartis’ once-daily multiple sclerosis (MS) drug Gilenya.

The Gilenya sanction covers use of the drug for preventing relapse and delaying progression of physical disability in adult MS patients.

The only other drug licensed in Japan for preventing relapse of MS patients is interferon beta. ... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1309
MS-UK - http://www.ms-uk.org/
User avatar
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 3:00 pm


Return to Gilenya


  • Related topics
    Last post

Who is online

Users browsing this forum: No registered users

Contact us | Terms of Service